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ABSTRACTS OF SECOND INTERNATIONAL CONFERENCE ON ALZHEIMER'S  DISEASE 
BIOLOGICAL MARKERS/SYSTEMIC MARKERS 
We have examined SER functioning (a) by measuring basal 
and stimulated concentrations of intraplatelet free calcium 
([Ca2*]±) in reaponee to thrombln (1 unit/ml), using lure-2 and 
(h) hy meaeurlng th~s..~_~flc antlvit~es o f  calcium r~letlng 
enzymes such as, Ca /Mg" -ATPase, ~2 -ATPnse and Ca2"-ATPaae, 
using malachite green reagent for determination of inorganic 
phosphate. Our results (Table 1) show that, there was a 
significant increase in the percentage of [Ca2÷]i released above 
the basal levels with thro~In stimulation in AD platelets 
compared to controls. This was partly due to to a lower basal 
and a higher stimulated [Ca2÷]~ in AD platelets compared to 
controls. We have also found that, the epeciflc activities of 
Ca2*/Mg2÷-ATPaee, Ca2÷-ATPase but not Mg2÷-ATPaae were 
significantly reduced in AD plateleta co~paredto controls lTable 
1). 
These data suggest that calcium homeostasis is altered in 
AD plateleta. This is comparable to the findings in AD 
fibrohlasts 3 and might be important in the CNS pathophyeiology 
of this disorder. 
Table 1. 
Basal StimulAd~d tlncrease 
[Ca2+] i (.]/) 
ALS n=19 n=19 
149@21 545+50 3 0 5 + 1 9 - *  
tOM n=lO n=10 
198123 476±70 134~e 
Values are the Means ± SEM. 
MWZ+ ~÷/I~2+ ca2+ 
( , = . , , l e l = / . n / s ~ = o t )  
n=24 n-24 n=24 
7 . 4 ~ 0 . 4  9 . 6 i 0 . 6 "  2 . 2 i 0 . 3 "  
n=18 n=18 n=18 
8 . 8 ± 1 . 2  1 3 . 3 ~ 1 . 8  4 . 5 ± 0 . 9  
*p<0.OS, **p<ixl0-5; Significantly different from controls 
(unpaired t-test). 
Refere~ce~ 
1. Hi~ks, et al(1987)Alz.Dieeass & Associated Disorders.l,90-97. 
2. HaJimoh~mmadreza, et al(1990)Biochim.Biophys.Actalln press). 
3. Paterson, et al(1988)Neurobiol.Ageing.9,261-266. 
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DIFFERENT PATTERNS OF CSF MONOAMINE METABOLITES IN 
OLD-AGE DEMENTIAS. L. Parnetti, A. Gaiti ̂ , *P. 
Mecocci, D. Cadini, M. Brunetti ̂ , U. Senin. Chair of 
Gerontology and Geriatrics; ^Chair of Biochemistry, 
Perugia University, 08100 Perugia, ITALY. 
Many investigations have been carried out in recent 
years in an attempt to clarify the ethiopathogenetic 
role of neurotransmitter deficiencies in dementia 
disorders. With regard to "ex vivo" studies on bio- 
genic amines, which have importance in regulating 
cognitive and motor functions, attention has been 
focused on CSF levels of the key breakdown products 
of these neurotransmitters: homovanillic acid -HVA- 
for dopamine, 5-hydroxy-indoleacetic acid (5-MIAA) 
for serotonin and 3-methoxy-4-hydroxyphenyl-ethyl- 
glycol (MHPG) for norepinephrine, since they reflect 
the central monoaminergic activity. With the aim of 
better understanding the pathogenetic usefulness of 
these biological markers in dementia disorders,we 
have thus measured CSF levels of the main metaboli- 
tes of monoamines (HMPG, 5-HIAA and HVA) in patients 
with early-onset Alzheimer's disease (e-AD, n. 12), 
late-onset AD (I-AD, n. 13), vascular dementia (VD, 
n. 13), simple senile dementia (SSD, n.9) and twelve 
elderly controls. Psyehobehavioural assessment was 
also carried out by means of MMSE and GBS Rating 
Scale for Dementia. Mean HMPG levels did not differ 
from controls among the groups considered, while 5- 
HIAA was slightly lower (0.10>p>O.O5) in e-AD, I-AD 
and VD; HVA was consistently decreased (p<O.O2) in 
e-AD and I-AD, showing a slight reduction 
(0.10>p>O.05) in VD. No variation was found in SSD. 
Negative and differently distributed correlations 
between neuroohemical and psyehobehavioural parame- 
ters were observed in I-AD, VD and SSD groups while 
no relationship between these variables was documen- 
ted in e-AD. These results confirm that CSF levels 
of monoamine metabolites are of scarce diagnostic 
value but reinforce the evidence of the clinical 
heterogeneity of old-age dementias and the potential 
importance of these clinical-biological studies in 
view of differentiated therapeutical treatments. 
344 
VITAMINS, METALS AND ROUTINE BLOODCHEMISTRY IN 
NORMAL AGING: RESULTS FROM A MULTIPLE COHORT STUDY. 
*N. Bohnen, J. Jolles and C. DeEenaar. Dept of Neuropsychology & 
Psychobiology; Limburg University; Box 616; 6200 MD Maaet~eht; 
The Netherlands. 
Up till now, there is a very limited number of studies into blood 
parameters in normal aging: there are only few reports on a 
reasonably representative sample from the normal population who 
include young as well as old subjects. This restricts the possiblllties 
to study pathogenetlc factors with respect to blood parameters In 
age related diseases such as Alzheimer's disease, because reference 
values from healthy control subjects are needed for that purpose. 
The present research project aims at, first, providing objective 
information on age-dependent changes in blood levels of vitamins, 
metal ions and routine chemical parameters. The second objective 
was the establishment of objective norms for a comparison with 
AD, and depression. The study was performed on 4 cohorts of 
healthy subjects who had undergone a rigorous healthscreening in 
order to exclude biasing factors such as risc factors for brain 
dysfunction and dysfunctions in the realm of internal medicine. The 
cohorts were 20 (±3), 40 (+3), 60 (±3) and 80 (±3) with l0 males 
and 10 females per cohort. Venous blood samples were collected 
after an overnight fast between 8.00 and 9.00 am. The parameters 
under investigation were: vitamins, metals, hormones and routine 
blood biochemistry. The effects of age and sex were evaluated for 
each variable by ANOVA, From the 19 routine parameters (Na, H, 
Cl, Ca, Ca-ion, P, Fe, Mg, plasmaosmolallty, total protein, albumin, 
triglycerids, cholesterol, BUN, creatinin, liver enzymes and alcaline 
phosphathase), 11 demonstrated significant abnormalities related to 
age and these included Ca, P, Albumin, Cholesterol, BUN, creatinin, 
liver enzymes and alcaline phosphase. In addition there were sex 
related differences in aging (for example Fe, albumin and BUN) 
Further results in this disease-free population are that there is no 
evidence of a decline of blood vitamin levels (B1, B2. B6, B12 and 
C) with aging. Furthermore nutrition dependant elements change in 
normal aging (such as zinc). The results with respect to trace- 
metals, neurotoxic elements and hormones will be reported at a 
later occasion. The findings may have an important impact in that 
they provide norms for a well characterised healthy aging popula- 
tion. In addition, this population appears characterised by age 
related changes in several blood parameters without change in 
vitamins. Age related decreases in vitamins found in earlier studies 
may be the  r e s u l t  of i nc lu s ion  of n o n - h e a l t h y  i n d i v i d u a l s  in the  sample.  
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CORRELATIONS BETWEEN AND AMONG PURINES AND PURINE 
METABOLITES IN ALZHEIMER'S DISEASE. * P.E. Milbury 1, E.A. 
Ryan 1, M.F. BealZ W.R. Matson ~, ~ESA, Inc., Bedford, MA 01730 
USA and 2Massachusetts General Hospital, Dept. of Neurology, 
Boston, MA 02114 USA. 
Through the utilization of large, multiparameter data 
bases containing sufficiently reliable information, data which 
may seem chaotic can be used in the definition of normal 
metabolism and the altered state metabolism associated with 
specific disorders. Studies of patients with neuropsychiatric 
disorders suggest that dietary levels of tryptophan and 
tyrosine profoundly affect the levels of various 
neurotransmitters. Deficiencies in purine metabolism have 
been linked to neurochemical lesion in Parkinson's Disease, 
while variations in purine metabolites have been implicated in 
Alzheimer type dementias. 
A multiparameter data base has been created utilizing a 
Coulochem ® Electrode Array System. Approximately 1000 
Alzheimer, Huntington, Parkinson, control tissue and CSF 
samples comprise this data base. We have analyzed these data 
for potential metabolic interactions between the purine, 
tyrosine and tryptophan pathways. A strong correlation has 
been observed between levels of tyrosine and xanthine. 
Tyrosine/xanthine ratios were found to be significantly 
decreased in the putamen and A4 of the Parkinson samples. 
Guanosine levels in putamen, A20, A21, A9, and A4 in 
Alzheimer samples were decreased approximately 50 percent 
of control values. Alterations in the metabolism of purines 
were associated with changes in the tyrosine/tryptophan 
pathways. These data suggest a relationship between purine 
and aromatic amino acid metabolism in certain central 
disease disorders. 
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THE EEG SPECTRA OF ALZHEIMER'S DISEASE, *D. Clannltrapanl, 
J. Collins and D, Vaaslliadls. Department of Veterans Affairs 
Medical Center, Perry Point, MD. 21902 USA. 
